Success Metrics

Clinical Success Rate

75.0%

Based on 6 completed trials

Completion Rate

75%(6/8)

Active Trials

1(11%)

Results Posted

83%(5 trials)

Terminated

2(22%)

Phase Distribution

Ph phase_3

44%

Ph phase_1

11%

Ph phase_2

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

1(12.5%)

Phase 2Efficacy & side effects

3(37.5%)

Phase 3Large-scale testing

4(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(6)

Terminated(2)

Detailed Status

Completed6

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (12.5%)

Phase 23 (37.5%)

Phase 34 (50.0%)

Trials by Status

completed667%

recruiting111%

terminated222%

Recent Activity

1 active trials

Showing 5 of 9

completed

Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant

NCT04340505

recruitingphase_3

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

NCT05844982

completedphase_1

Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis

NCT01781936

terminatedphase_2

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

NCT00695318

terminatedphase_2

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

NCT00770770

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT04340505

Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant

Completed

NCT05844982Phase 3

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Recruiting

NCT01781936Phase 1

Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis

Completed

NCT00695318Phase 2

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

Terminated

NCT00770770Phase 2

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

Terminated

NCT01304706Phase 3

Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study

Completed

NCT00344968Phase 3

Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema

Completed

NCT00490815Phase 3

Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema

Completed

NCT00502541Phase 2

Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema

Completed

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9